Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-06
1998-05-05
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
057475040
ABSTRACT:
The invention relates to a method of treating cardiac insufficiency by using compounds of the formula I ##STR1## in which n is 1 or 2, R, R.sup.1, R.sup.2 and R.sup.3 are identical or different and each denote hydrogen or an organic radical and R.sup.4 and R.sup.5, together with the atoms carrying them, form a mono-, bi- or tri-cyclic heterocyclic ring system. The invention furthermore relates to compounds of the formula I and agents containing these for use in the treatment of the abovementioned disease.
REFERENCES:
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4350704 (1982-09-01), Hoefle et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4374847 (1983-02-01), Gruenfeld
patent: 4404206 (1983-09-01), Vincent et al.
patent: 4425355 (1984-01-01), Hoefle et al.
patent: 4442089 (1984-04-01), Horovitz
patent: 4508729 (1985-04-01), Vincent et al.
patent: 4515803 (1985-05-01), Henning et al.
patent: 4525301 (1985-06-01), Henning et al.
patent: 4558064 (1985-12-01), Teetz et al.
patent: 4558065 (1985-12-01), Urbach et al.
patent: 4562202 (1985-12-01), Urbach et al.
patent: 4565819 (1986-01-01), Vincent et al.
patent: 4584285 (1986-04-01), Doll et al.
patent: 4584299 (1986-04-01), Steffen et al.
patent: 4587258 (1986-05-01), Gold et al.
patent: 4591598 (1986-05-01), Urbach et al.
patent: 4614805 (1986-09-01), Urbach et al.
patent: 4620012 (1986-10-01), Henning et al.
patent: 4624962 (1986-11-01), Henning et al.
patent: 4659838 (1987-04-01), Lerch
patent: 4668796 (1987-05-01), Geiger et al.
patent: 4668797 (1987-05-01), Urbach et al.
patent: 4678800 (1987-07-01), Stanton et al.
patent: 4684662 (1987-08-01), Henning et al.
patent: 4691022 (1987-09-01), Henning et al.
patent: 4714708 (1987-12-01), Urbach et al.
patent: 4727160 (1988-02-01), Teetz et al.
patent: 4808573 (1989-02-01), Gold et al.
patent: 4818749 (1989-04-01), Gold et al.
patent: 4822894 (1989-04-01), Geiger et al.
patent: 4831157 (1989-05-01), Gold et al.
patent: 4849524 (1989-07-01), Henning et al.
patent: 4868307 (1989-09-01), Barton et al.
patent: 4879403 (1989-11-01), Teetz et al.
patent: 4886827 (1989-12-01), Urbach et al.
patent: 4920144 (1990-04-01), Urbach et al.
patent: 4933361 (1990-06-01), Urbach et al.
patent: 4983623 (1991-01-01), Henning et al.
patent: 4997260 (1991-03-01), Henning et al.
patent: 5053519 (1991-10-01), Teetz et al.
patent: 5055483 (1991-10-01), Ruger et al.
patent: 5061722 (1991-10-01), Teetz et al.
patent: 5098910 (1992-03-01), Becker et al.
Gross, Chemical Abstract 100: 151036a (1983).
Ader et al, Circulation, 61 (5) (1980), pp. 931-937.
Gavras et al, Circulation, 58 (5), (1978), pp. 770-776.
Dorland's Medical Dictionary, 24th Ed (1965), W.B Saunders Co. pp. 649 and 746.
Effect of Ramipril on Mortality and Morbidity of Survivors of Acute Myocardial Infaction with Clinical Evidence of Heart Failure, The Acute Infaction Ramipril Efficacy (AIRE) Study Investigators, The Lancet, Oct. 2, 1993, vol. 342, No. 8875.
Drug Evaluations, 6th Ed. (1986), American Medical Assn., pp. 429-434 and 535-536.
Teetz, CA(100):52012h (1984), p. 617.
Urbach, CA(100):139616g (1984), p. 702.
Urbach, CA(100):139617h (1984), p. 702.
Henning, CA(100):210436f (1984), p. 655.
Geiger, CA(97):92759h (1982), p. 819.
Leonard et al., J. Am. Chem. Soc., 77, 439 (1955).
Leonard et al., J. Am. Chem. Soc., 78, 3457 (1956).
Leonard et al., J. Am. Chem. Soc., 78, 3463 (1956).
Leonard et al., J. Am. Chem. Soc., 81, 5627 (1959).
Koelsch et al., J. Org. Chem., 26, 1104 (1961).
Griot et al., Helv. Chim. Acta, 42, 121 (1959).
Bonnett et al., J. Chem. Soc., 2087 (1959).
Battersby et al., J. Chem. Soc., 4333 (1958).
Rosenblatt et al., The Chemistry of Functional Groups, Supplement F: The Chemistry of Amino, Nitroso and Nitro Compounds and Their Derivatives, Part II, S. Patai, ed., Wiley & Sons: New York, 1982, pp. 1100-1104.
L.W. Haynes, Enamines, A.G. Cook, ed., Marcel Decker, Inc.: 1969, pp. 68-79, 261-269, 413.
Fieser & Fieser, Reagents for Organic Synthesis, vol. 1, pp. 644-651 (1967).
Boehme et al., Iminium Salts in Organic Chemistry, Part I (E.C. Taylor, ed.), Wiley & Sons: New York, 1976, p. 143.
S. Dayagi et al., The Chemistry of Functional Groups, The Chemistry of the Carbon-Nitrogen Double Bond, S. Patai, ed., Wiley & Sons: New York, 1970, p. 119.
W. Greenlee et al., J. Med. Chem., 28, 434,442 (1985).
K. Ogawa et al., J. Chem. Soc., Perkin Trans. I, 3031-3035 (1982).
R. Bacon and D. Stewart, J. Chem. Soc. (C), 1384-1387 (1966).
R. Bacon et al., J. Chem. Soc. (C), 1388-1389 (1966).
Patchett et al., Nature, 288, 280-283 (1980).
Booth et al., Chemistry and Industry, 466-467 (1956).
Booth et al., J. Chem. Soc., Part I, 1050-1054 (1959).
Murakoshi et al., Chemical Abstracts, 61, 9465(e) (1964).
Cushman et al., Fed. Proc., 38 (13), 2778-2782 (1979).
Houben-Weyl, Methoden er Organischen Chemie, 7(2b), 1403-1404 (1976).
Katritskaya, Dzh. Lagorskaya Khimia Geterosikl. Soedin., Moskow, 1963, pp. 155-158.
Anderson, Jr. et al., J. Org. Chem., 43(1), 54-57 (1978). Berichte, 92(7), 2218-2235 (1959).
Farkas et al., J. Org. Chem., 22, 1261-1263 (1957).
Taylor et al., J. Org. Chem., 38(16), 2817-2821 (1973).
Taylor et al., Heterocycles, 25, 343-345 (1987).
English language translation of Mitzlaff et al., Liebig's Ann. Chem., 1713-1733 (1978).
Quarterly Reviews 25: 323-341 (1971).
Chem. Berichte 86: 1524-1528 (1953).
Chem. Abst. 49/1955/3009c.
Xiang et al. Chem. Abstracts, CA (100):150853c (1984), p. 3.
Teetz et al., Chemical Abstract, vol. 99, No. 158854k (1983).
Gross, F., Chemical Abstract, vol. 100, No. 1510369 (1983).
Urbach et al., Chemical Abstract, vol. 103, No. 160858 (1985).
Stedman's Medical Dictionary, 22nd Ed. (1972), The Williams and Wilkins Company, Baltimore, p. 638.
The Merck Manual, 15th Ed. (1987), Berkow M.D. editor, pp. 401, 428-429.
Gavras et al., Circulation, vol. 58, No. 5 (1978), pp. 770-776.
Ader et al., Circulation, vol. 61,. No. 5 (1980), pp. 931-937.
Bernward Scholkens et al., "Experimental Cardiovascular Benefits of Angiotensin--Converting Enzyme Inhibitors: Beyond Blood Pressure Reduction," J. Cardiovasc. Pharmacol., vol. 18 (Supp. 2), pp. S26-S30 (1991).
A. Gavazzi, R. Marioni, C. Campana & C. Montemartini, Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure, Journal of Hypertension, 1994, 12 (suppl 4); 589-593.
D. Canter, G. Frank, L. Knapp and R. McLain, The Safety Profile of Quinapril: Is There a Difference Among ACE Inhibitors?, Clin. Cardiol. 13, VII-39-42 (1990).
Ryozo Koshiura et al., "Naibumpi Yakuri" (Endocrinological Pharmacology) pp. 136-137 (Jun. 10, 1983) (w/English translation of passages).
Geiger Rolf
Henning Rainer
Scholkens Bernward
Teetz Volker
Urbach Hansjorg
Ford John M.
Hoechst Aktiengesellschaft
LandOfFree
Method of treating cardiac insufficiency using angiotensin-conve does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cardiac insufficiency using angiotensin-conve, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cardiac insufficiency using angiotensin-conve will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55004